Introduction Early HER2-positive breast cancer requires timely initiation of anti-HER2 therapy to optimize outcomes. In low- and middle-income countries (LMICs), health-system constraints—ranging from diagnostic delays to treatment access barriers—can slow this process. This retrospective cohort study examines whether a structured Patient Navigation Program (PNP) can reduce the time from diagnosis to initiation of anti-HER2 therapy…